[1]
I. B. Syed and M. Nannapaneni, “Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS”, ijpi, vol. 13, no. 1, pp. 113-121, Dec. 2022.